Actively Recruiting

Early Phase 1
Age: 13Years - 21Years
All Genders
NCT05509257

Naltrexone Neuroimaging in Teens With Eating Disorders

Led by Children's Mercy Hospital Kansas City · Updated on 2025-11-25

60

Participants Needed

1

Research Sites

245 weeks

Total Duration

On this page

Sponsors

C

Children's Mercy Hospital Kansas City

Lead Sponsor

U

University of Kansas Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

Using a randomized, placebo-controlled, crossover study, this study will evaluate functional magnetic resonance imaging (fMRI) as a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders. The hypothesis is that fMRI will be able to detect acute reward pathway modulation by naltrexone (an opioid antagonist) in pre-defined regions of interest (anterior cingulate cortex, nucleus accumbens, dorsolateral prefrontal cortex).

CONDITIONS

Official Title

Naltrexone Neuroimaging in Teens With Eating Disorders

Who Can Participate

Age: 13Years - 21Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adolescents and young adults aged 13-21 years
  • Diagnosis of an eating disorder with binge eating and/or purging using DSM-V criteria
  • Stable medication regimen with no dose or drug changes in the past 4 weeks
  • Willingness and ability of participant and parent/legal guardian (if under 18) to provide informed permission/assent/consent
Not Eligible

You will not qualify if you...

  • Pregnant
  • Prior hypersensitivity reaction to naltrexone, including anaphylaxis
  • Presence of non-removable metal in the body incompatible with MRI
  • Current use of naltrexone
  • Self-reported opioid use in the past 7 days
  • Language barrier preventing communication or completion of study requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Children's Mercy Research Institute

Kansas City, Missouri, United States, 64108

Actively Recruiting

Loading map...

Research Team

M

Mariah L Brewe, BA

CONTACT

S

Stephani Stancil, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here